Elevance slides as Humana wins the 2027 Medicare star ratings
Elevance Health (ELV) fell on October 9 after new federal quality scores for 2027 Medicare Advantage plans favored rival Humana. Those stars drive bonus payments that fund richer benefits, so a slip means weaker footing next year. Seth Klarman holds ELV at nearly 11% of the tracked book.